BridgeMD
New treatment option for Emergence Agitation
Official title Effect of Lollipop on Emergence Delirium in Pediatric Patients Undergoing General Anesthesia
ClinicalTrials.gov ID: NCT07571707
What this study is testing
- What it's testing
- This study aims to evaluate the effectiveness of lollipop administration after surgery in reducing emergence agitation in pediatric patients undergoing anesthesia with sevoflurane at RS Ngoerah. Emergence agitation is a common condition in children after general anesthesia, characterized by restlessness, confusion, and distress during recovery.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 2 to 6
You may be able to join if
- Pediatric patients aged 2-6 years
- Scheduled for elective surgery under general anesthesia with sevoflurane
- American Society of Anesthesiologists (ASA) physical status I-II
- Written informed consent obtained from parents or legal guardians
You likely can't join if
- Known allergy or contraindication to study-related procedures
- Developmental delay or neurological disorders affecting behavior assessment
- Use of sedative or psychoactive medications prior to surgery
- History of emergence delirium or significant behavioral disorders
- Intraoperative complications requiring deviation from standard anesthesia protocol
The study team makes the final eligibility decision.
Where it's taking place
- Denpasar, Bali, Indonesia
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 2 years to 6 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Denpasar, Bali, Indonesia. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.